In the Race for Alternative MOA Biologic in Crohn's Disease Takeda's Entyvio Maintains the Lead but Janssen's Stelara is Gaining Fast

EXTON Pa. June 27 2017 PRNewswire Spherix Global Insights has just released the second quarter results of an independent survey regarding the evolving practice patterns in the management of Crohn's disease CD. Study findings reveal that despite only minor...